| Muhammad Muslim Mubashir, MD | |
|
994 W Jericho Tpke Ste 104, Smithtown, NY 11787-3211 | |
| (631) 543-1440 | |
| Not Available |
| Full Name | Muhammad Muslim Mubashir |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 994 W Jericho Tpke Ste 104, Smithtown, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376064170 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | 318905 (New York) | Secondary |
| 207L00000X | Anesthesiology | 318905 (New York) | Primary |
| Entity Name | Timothy D. Groth Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720022015 PECOS PAC ID: 8921002320 Enrollment ID: O20060825000424 |
News Archive
Protalix BioTherapeutics, Inc.,a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell based expression system, today announced that the Company's common stock has been approved for listing on the Tel Aviv Stock Exchange in addition to its current listing on the NYSE Amex.
Luitpold Pharmaceuticals, Inc. today announced that it has temporarily suspended distribution of all of its drug products manufactured at its Shirley, New York facility and marketed by its American Regent, Inc. subsidiary and Animal Health Division.
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
Morbidly obese patients who undergo a particular type of gastric bypass surgery called Roux-en-Y gastric bypass (RYGB) are at an increased risk of developing kidney stones - small, pebble-like deposits that can result in severe pain and require an operation to remove them - earlier than previously thought. These stones develop in patients within only a few months following the procedure rather than several months to years, according to research published in the June issue of the Journal of the American College of Surgeons.
In the culmination of decades of research at the University of Virginia Health System, doctors have begun human testing of a drug they hope will one day save many lives among lung transplant recipients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Muhammad Muslim Mubashir, MD 994 W Jericho Tpke Ste 104, Smithtown, NY 11787-3211 Ph: (631) 543-1440 | Muhammad Muslim Mubashir, MD 994 W Jericho Tpke Ste 104, Smithtown, NY 11787-3211 Ph: (631) 543-1440 |
News Archive
Protalix BioTherapeutics, Inc.,a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell based expression system, today announced that the Company's common stock has been approved for listing on the Tel Aviv Stock Exchange in addition to its current listing on the NYSE Amex.
Luitpold Pharmaceuticals, Inc. today announced that it has temporarily suspended distribution of all of its drug products manufactured at its Shirley, New York facility and marketed by its American Regent, Inc. subsidiary and Animal Health Division.
Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant and related aerosolization technologies as first in class therapies for severe respiratory diseases, today provides an update on key pipeline and business initiatives and reports financial results for the second quarter ended June 30, 2010.
Morbidly obese patients who undergo a particular type of gastric bypass surgery called Roux-en-Y gastric bypass (RYGB) are at an increased risk of developing kidney stones - small, pebble-like deposits that can result in severe pain and require an operation to remove them - earlier than previously thought. These stones develop in patients within only a few months following the procedure rather than several months to years, according to research published in the June issue of the Journal of the American College of Surgeons.
In the culmination of decades of research at the University of Virginia Health System, doctors have begun human testing of a drug they hope will one day save many lives among lung transplant recipients.
› Verified 1 days ago
Dr. Vineet Gambhir, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 48 Route 25a, Suite 101, Smithtown, NY 11787 Phone: 631-862-3413 Fax: 631-862-3604 | |
Dr. Doris Tamai, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 48 Route 25a, Suite 101, Smithtown, NY 11787 Phone: 631-862-3413 Fax: 631-862-3604 | |
Dr. Salvatore Daniel Buffa, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 50 Route 25a, Smithtown, NY 11787 Phone: 631-862-3413 Fax: 631-862-3604 | |
Timothy D Groth, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 994 W Jericho Tpke, Suite 104, Smithtown, NY 11787 Phone: 631-543-1440 Fax: 631-543-1930 | |
Dr. Jeany Pierre-louis, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 48 Route 25a, Suite 101, Smithtown, NY 11787 Phone: 631-862-3413 Fax: 631-862-3604 | |
Dr. Anthony Bonanno, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 50 Route 25a, Smithtown, NY 11787 Phone: 631-862-3413 Fax: 631-862-3604 | |
Dr. Steven Cohen, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 48 Route 25a, Suite 101, Smithtown, NY 11787 Phone: 631-862-3413 Fax: 631-862-3604 |